Remote ischemic conditioning improves cognition in patients with subcortical ischemic vascular dementia
Open Access
- 23 August 2019
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 19 (1) , 1-8
Abstract
Subcortical ischemic vascular dementia (SIVD) is very common among the older people, but has no approved treatment. Preclinical trials show that remote ischemic conditioning (RIC) reduces recurrence of ischemic stroke. We hypothesize that RIC may also be an effective therapy for patients with SIVD. Thirty-seven consecutive SIVD cases were enrolled in this randomized control study. Eighteen RIC patients underwent five brief cycles of conditioning (bilateral upper limb compression at 200 mmHg) followed by reperfusion twice daily over 6 consecutive months. Nineteen control patients underwent the same process, but at a pressure of 60 mmHg which caused no restriction on the blood flow of the upper limb. The primary outcome measures were changes in neuropsychological assessments. The secondary outcomes included the changes in high-sensitive C-reactive protein (hs-CRP) concentration, white matter lesion volume (WMLV), diffusion tension imaging (DTI) metrics of white matter. All data were collected at baseline and follow-up. A significant treatment difference favoring RIC at 6 months was observed on performance of Hopkins Verbal Learning Test-Revised (HVLT-R), Controlled Oral Word Association Test (COWAT), Trail Making Test A and B (TMT-A & TMT-B), and Judgment of Line Orientation (JLO) (p < 0.05). The control group did not show much improvement after the treatment, and only with a slight change in HVLT-R and TMT-R (p < 0.05). Covariance analysis of efficacy between the two groups suggested that RIC patients performed better on JLO than control patients at the 6-month follow-up (RIC 23.10 vs. control 18.56; p = 0.013). Although DTI metrics were comparable, Hs-CRP levels and WMLV in RIC patients showed a declining trend. Over the 6-month treatment period, we found that RIC was safe and effective for improving cognitive function in SIVD patients. Clinical Trial Registration ( http://www.clinicaltrials.gov ), Unique identifier: NCT 03022149; Retrospectively registered; Date of registration: January 16, 2017.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81322018, 81273287, 81100887)
- National Natural Science Foundation of China (81801197)
- Youth Incubation Fund of Tianjin Medical University General Hospital (ZYYFY2017004)
This publication has 29 references indexed in Scilit:
- Remote Ischemic Conditioning in Cerebral Diseases and Neurointerventional Procedures: Recent Research ProgressFrontiers in Neurology, 2018
- Limb Remote Ischemic Conditioning: Mechanisms, Anesthetics, and the Potential for Expanding Therapeutic OptionsFrontiers in Neurology, 2018
- Intravoxel Incoherent Motion Imaging in Small Vessel DiseaseStroke, 2017
- Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer’s diseaseBMC Medicine, 2017
- Vascular dementiaThe Lancet, 2015
- Cognitive correlates of white matter lesion load and brain atrophyNeurology, 2015
- The effects of DL‐3‐n‐butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double‐blind, placebo‐controlled trialAlzheimer's & Dementia, 2015
- Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicabilityJournal of Cerebral Blood Flow & Metabolism, 2015
- Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosisNeurology, 2012
- Subcortical ischaemic vascular dementiaThe Lancet Neurology, 2002